Innovax-ND-IBD
Authorised
This medicine is authorised for use in the European Union
Newcastle disease / infectious bursal disease / Marek's disease vaccine (live recombinant)
MedicineVeterinaryAuthorised
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.
Innovax-ND-IBD : EPAR - Medicine overview
Reference Number: EMA/391280/2017
English (EN) (81.94 KB - PDF)
First published: Last updated:
български (BG) (93.36 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
español (ES) (81.97 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
čeština (CS) (93.99 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
dansk (DA) (83.34 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
Deutsch (DE) (82.76 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
eesti keel (ET) (82.18 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
ελληνικά (EL) (93.76 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
français (FR) (82.44 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
hrvatski (HR) (92.27 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
íslenska (IS) (83.29 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
Gaeilge (GA) (83.57 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
italiano (IT) (82.29 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
latviešu valoda (LV) (94.29 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
lietuvių kalba (LT) (94.03 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
magyar (HU) (94.15 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
Malti (MT) (95.95 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
Nederlands (NL) (82.05 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
norsk (NO) (82 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
polski (PL) (95.62 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
português (PT) (83.01 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
română (RO) (94.17 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
slovenčina (SK) (94.08 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
slovenščina (SL) (82.27 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
Suomi (FI) (81.54 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
svenska (SV) (82.05 KB - PDF)
First published: 21/09/2017Last updated: 09/03/2021
Product information
Innovax-ND-IBD : EPAR - Product Information
English (EN) (81.49 KB - PDF)
First published: Last updated:
български (BG) (91.78 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
español (ES) (81.51 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
čeština (CS) (92.48 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
dansk (DA) (82.05 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Deutsch (DE) (81.72 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
eesti keel (ET) (81.22 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
ελληνικά (EL) (91.79 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
français (FR) (81.63 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
hrvatski (HR) (91.56 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
íslenska (IS) (81.52 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Gaeilge (GA) (81.36 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
italiano (IT) (81.76 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
latviešu valoda (LV) (92.14 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
lietuvių kalba (LT) (92.19 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
magyar (HU) (92.76 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Malti (MT) (93.86 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Nederlands (NL) (81.15 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
norsk (NO) (81.52 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
polski (PL) (93.22 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
português (PT) (82.53 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
română (RO) (91.73 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
slovenčina (SK) (81.75 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
slovenščina (SL) (81.76 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Suomi (FI) (81.11 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
svenska (SV) (81.47 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Latest procedure affecting product information:
WS2102/G
Innovax-ND-IBD : EPAR - All Authorised presentations
English (EN) (81.94 KB - PDF)
First published: Last updated:
български (BG) (93.36 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
español (ES) (81.97 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
čeština (CS) (93.99 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
dansk (DA) (83.34 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Deutsch (DE) (82.76 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
eesti keel (ET) (82.18 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
ελληνικά (EL) (93.76 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
français (FR) (82.44 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
hrvatski (HR) (92.27 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
íslenska (IS) (83.29 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Gaeilge (GA) (83.57 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
italiano (IT) (82.29 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
latviešu valoda (LV) (94.29 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
lietuvių kalba (LT) (94.03 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
magyar (HU) (94.15 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Malti (MT) (95.95 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Nederlands (NL) (82.05 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
norsk (NO) (82 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
polski (PL) (95.62 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
português (PT) (83.01 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
română (RO) (94.17 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
slovenčina (SK) (94.08 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
slovenščina (SL) (82.27 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Suomi (FI) (81.54 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
svenska (SV) (82.05 KB - PDF)
First published: 21/09/2017Last updated: 04/11/2021
Product details
- Name of medicine
- Innovax-ND-IBD
- Active substance
- Cell-associated live recombinant turkey herpesvirus (strain HVP360), expressing the fusion protein of ND virus and the VP2 protein of IBD virus
- International non-proprietary name (INN) or common name
- Newcastle disease
- infectious bursal disease
- Marek's disease vaccine (live recombinant)
Authorisation details
- EMA product number
- EMEA/V/C/004422
Assessment history
Innovax-ND-IBD : EPAR - Procedural steps taken and scientific information after the authorisation
English (EN) (81.94 KB - PDF)
First published: Last updated:
Innovax-ND-IBD-V-C-4422-II-0004 : EPAR - Assessment report - Variation
AdoptedReference Number: EMA/193705/2019
English (EN) (81.49 KB - PDF)
First published:
CVMP post-authorisation summary of positive opinion for Innovax-ND-IBD (II/0004)
AdoptedReference Number: EMA/CVMP/507630/2020
English (EN) (129.06 KB - PDF)
First published:
Innovax-ND-IBD-V-C-4422-X-0001 : EPAR - Assessment report - Extension
AdoptedReference Number: EMA/193705/2019
English (EN) (81.49 KB - PDF)
First published:
CVMP post-authorisation summary of positive opinion for Innovax-ND-IBD (X-001)
AdoptedReference Number: EMA/CVMP/153784/201
English (EN) (68.25 KB - PDF)
First published:
Innovax-ND-IBD : EPAR - Public assessment report
Reference Number: EMA/377164/2017
English (EN) (81.49 KB - PDF)
First published: Last updated:
CVMP summary of positive opinion for Innovax-ND-IBD
AdoptedReference Number: EMA/CVMP/290079/2017
English (EN) (68.61 KB - PDF)
First published: Last updated:
News on Innovax-ND-IBD
This page was last updated on